Chao, Ting-Ting et al
"TD-19, an Erlotinib Derivative, Induces Epidermal Growth Factor Receptor Wild-Type Nonsmall-Cell Lung Cancer Apoptosis through CIP2A-Mediated Pathway." Journal of Pharmacology and Experimental Therapeutics
351.2
(2014):
352-358.
Web. 19 April. 2024.